VLG reports strong revenue growth of 28% to £7.8m in the H117 period – or 18% on a like-for-like basis – as investment in promotion of the UltraDEX oral care range paid off, indicating that VLG is well on track to deliver our FY17 estimated revenue. We estimate that line extensions, prospects of further international expansion of the brand, will be a key driver of future margin and revenue growth. There are also indications that the Biokosmes manufacturing site is increasing output and revenues, having achieved a record high in sales in June. We maintain our forecasts ahead of FY17 results.
13 Jul 2017
Delivering strong revenue momentum
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Delivering strong revenue momentum
Venture Life Group Plc (VLG:LON) | 38.8 0.3 2.0% | Mkt Cap: 49.0m
- Published:
13 Jul 2017 -
Author:
Emma Ulker -
Pages:
2
VLG reports strong revenue growth of 28% to £7.8m in the H117 period – or 18% on a like-for-like basis – as investment in promotion of the UltraDEX oral care range paid off, indicating that VLG is well on track to deliver our FY17 estimated revenue. We estimate that line extensions, prospects of further international expansion of the brand, will be a key driver of future margin and revenue growth. There are also indications that the Biokosmes manufacturing site is increasing output and revenues, having achieved a record high in sales in June. We maintain our forecasts ahead of FY17 results.